List of Taiga Biotechnologies patents

Patents where

Current Assignee

Name

Taiga Biotechnologies

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11369678 Compositions and methods for modulating immune cells	Patent 11369678 was granted and assigned to Taiga Biotechnologies on June, 2022 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	11369678	June 28, 2022
‌ US Patent 9169462 Methods for preparing mature erythrocytes from conditionally immortalized hematopoietic stem cells	Patent 9169462 was granted and assigned to Taiga Biotechnologies on October, 2015 by the United States Patent and Trademark Office.		Taiga Biotechnologies	United States Patent and Trademark Office	9169462	October 27, 2015
‌ US Patent 10442853 Antibodies and processes for preparing the same	Patent 10442853 was granted and assigned to Taiga Biotechnologies on October, 2019 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10442853	October 15, 2019
‌ US Patent 10087420 Expansion of adult stem cells in vitro	Patent 10087420 was granted and assigned to Taiga Biotechnologies on October, 2018 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10087420	October 2, 2018
‌ US Patent 9365825 Expansion of adult stem cells in vitro	Patent 9365825 was granted and assigned to Taiga Biotechnologies on June, 2016 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	9365825	June 14, 2016
‌ US Patent 10272115 Production and use of red blood cells	Patent 10272115 was granted and assigned to Taiga Biotechnologies on April, 2019 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10272115	April 30, 2019
‌ US Patent 8986702 Antibodies and processes for preparing the same	Patent 8986702 was granted and assigned to Taiga Biotechnologies on March, 2015 by the United States Patent and Trademark Office.		Taiga Biotechnologies	United States Patent and Trademark Office	8986702	March 24, 2015
‌ US Patent 10864259 Methods and compositions for the treatment of melanoma		Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10864259	December 15, 2020
‌ US Patent 8828723 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC	Patent 8828723 was granted and assigned to Taiga Biotechnologies on September, 2014 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	8828723	September 9, 2014
‌ US Patent 10206952 Enhanced reconstitution and autoreconstitution of the hematopoietic compartment	Patent 10206952 was granted and assigned to Taiga Biotechnologies on February, 2019 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10206952	February 19, 2019
‌ US Patent 10953048 Enhanced reconstitution and autoreconstitution of the hematopoietic compartment	Patent 10953048 was granted and assigned to Taiga Biotechnologies on March, 2021 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10953048	March 23, 2021
‌ US Patent 11116796 Nanoparticle formulations	Patent 11116796 was granted and assigned to Taiga Biotechnologies on September, 2021 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	11116796	September 14, 2021
‌ US Patent 8784825 Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC	Patent 8784825 was granted and assigned to Taiga Biotechnologies on July, 2014 by the United States Patent and Trademark Office.		Taiga Biotechnologies	United States Patent and Trademark Office	8784825	July 22, 2014
‌ US Patent 9428571 Antibodies and processes for preparing the same	Patent 9428571 was granted and assigned to Taiga Biotechnologies on August, 2016 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	9428571	August 30, 2016
‌ US Patent 9775897 Modulators of MYC and methods of using the same	Patent 9775897 was granted and assigned to Taiga Biotechnologies on October, 2017 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	9775897	October 3, 2017
‌ US Patent 10786534 Production and use of red blood cells	Patent 10786534 was granted and assigned to Taiga Biotechnologies on September, 2020 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10786534	September 29, 2020
‌ US Patent 10556006 Compositions and methods for modulating an immune response	Patent 10556006 was granted and assigned to Taiga Biotechnologies on February, 2020 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10556006	February 11, 2020
‌ US Patent 9789135 Enhanced reconstitution and autoreconstitution of the hematopoietic compartment	Patent 9789135 was granted and assigned to Taiga Biotechnologies on October, 2017 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	9789135	October 17, 2017
‌ US Patent 10149898 Methods and compositions for the treatment of melanoma	Patent 10149898 was granted and assigned to Taiga Biotechnologies on December, 2018 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10149898	December 11, 2018
‌ US Patent 10583156 Nanoparticle formulations	Patent 10583156 was granted and assigned to Taiga Biotechnologies on March, 2020 by the United States Patent and Trademark Office.	Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	10583156	March 10, 2020
‌ US Patent 11667695 Antibodies and processes for preparing the same		Taiga Biotechnologies	Taiga Biotechnologies	United States Patent and Trademark Office	11667695	June 6, 2023

21 results

0 selected

21 results

0 selected